KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Other Non Operating Income: 2018-2020

Historic Other Non Operating Income for Castle Biosciences (CSTL) over the last 3 years, with Dec 2020 value amounting to -$1.4 million.

  • Castle Biosciences' Other Non Operating Income was N/A to $48,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year change of. This contributed to the annual value of -$1.4 million for FY2020, which is 126.80% down from last year.
  • As of FY2020, Castle Biosciences' Other Non Operating Income stood at -$1.4 million, which was down 126.80% from $5.2 million recorded in FY2019.
  • Castle Biosciences' 5-year Other Non Operating Income high stood at $5.2 million for FY2019, and its period low was -$1.4 million during FY2020.
  • Moreover, its 3-year median value for Other Non Operating Income was -$272,000 (2018), whereas its average is $1.2 million.
  • In the last 5 years, Castle Biosciences' Other Non Operating Income spiked by 2,016.54% in 2019 and then crashed by 126.80% in 2020.
  • Castle Biosciences' Other Non Operating Income (Yearly) stood at -$272,000 in 2018, then spiked by 2,016.54% to $5.2 million in 2019, then plummeted by 126.80% to -$1.4 million in 2020.